Indeed, E2-stimulated Cyclin D1 expression in ER+ve breast cancer cells largely relies on an enhancer element downstream of CCND1 coding sequence, corresponding to the predominant ER-α recruiting site. The gene discussed is CCND1; the disease is breast carcinoma.